Clinical Trial Update: Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG [EARLY_Phase 1]

View source ↗

Summary

This is an early-phase (Phase 1) clinical trial evaluating 18F-Fluciclovine PET-MRI imaging in low-grade glioma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma
• Low-grade Glioma

Drugs mentioned

• 18F-Fluciclovine (fluorine-18-fluciclovine)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Glioma, Low-grade Glioma | EARLY_Phase 1 | Status: RECRUITING